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Abstract
Background: Older patients are at high risk for poor outcomes after acute hospital admission. The mortality rate in
these patients is approximately 20%, whereas 30% of the survivors decline in their level of activities of daily living
(ADL) functioning three months after hospital discharge. Most diseases and geriatric conditions that contribute to
poor outcomes could be subject to pro-active intervention; not only during hospitalization, but also after discharge.
This paper presents the design of a randomised controlled clinical trial concerning the effect of a pro-active, multi-
component, nurse-led transitional care program following patients for six months after hospital admission.
Methods/Design: Three hospitals in the Netherlands will participate in the multi-centre, double-blind, randomised
clinical trial comparing a pro-active multi-component nurse-led transitional care program to usual care after
discharge. All patients acutely admitted to the Department of Internal Medicine who are 65 years and older,
hospitalised for at least 48 hours and are at risk for functional decline are invited to participate in the study. All
patients will receive integrated geriatric care by a geriatric consultation team during hospital admission.
Randomization, which will be stratified by study site and cognitive impairment, will be conducted during admission.
The intervention group will receive the transitional care bridge program, consisting of a handover moment with a
community care Care Nurse (CN) during hospital admission and five home visits after discharge. The control group
will receive ‘care as usual’ after discharge. The main outcome is the level of ADL functioning six months after
discharge compared to premorbid functioning measured with the Katz ADL index. Secondary outcomes include;
survival, cognitive functioning, quality of life, and health care utilization, satisfaction of the patient and primary care
giver with the transitional care bridge program. All outcomes will be measured at three, six and twelve months after
discharge. Approximately 674 patients will be enrolled to either the intervention or control group.
Discussion: The study will provide new knowledge on a combined intervention of integrated care during hospital
admission, a proactive handover moment before discharge and intensive home visits after discharge.
Trial registration: Trial registration number: NTR 2384.
Background
Hospitalisation is a hazardous event for patients of 65
years and older. Many older people are acutely admitted
to the hospital for reasons like an infection or gastroin-
testinal bleeding. This acute disease is often accompanied
by other chronic diseases as well as other impaired health
conditions such as delirium, falls and malnutrition which
complicate treatment during and after hospital admission
[1-4]. The complexity of diseases and other health condi-
tions make older patients prone for adverse hospital out-
comes including mortality, institutionalization and
functional decline [5,6]. Improving patient safety and pre-
vention of adverse hospital outcomes are considered
priorities in these patients.
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or more activities of daily living (ADL) after discharge
compared to premorbid ADL functioning, and has
become an increasingly important focus of care during
and after hospital admission as it is experienced by
15-50% of acutely hospitalized patients [7-9]. Decline in
ADL function frequently precedes acute hospital admis-
sion [10] and once ADL function is lost, it is difficult to
recover [11].
Several approaches to prevent functional decline have
been studied. The effect of comprehensive geriatric
assessment (CGA), an intervention consisting of
screening on the risk for adverse outcomes, a diagnos-
tic assessment on the presence of geriatric conditions
and tailor-made interventions provided by a multidisci-
plinary team has most often been studied, showing
mixed results. Studies conducted on specialised geria-
tric units have demonstrated the effectiveness of the
CGA approach [12]. However, in studies on inpatient
geriatric consultation services where a multidisciplinary
team visits patients on different units, effects differ
[13]. Main components of successful studies were tar-
geting interventions to patients at risk for adverse out-
comes and following patients after discharge.
Other approaches often studied are 1) intensive dis-
charge planning and home follow-up after discharge
[14,15] and 2) transitional care [16]. These approaches
demonstrated to be effective to prevent rehospitalisation
and length of hospital stay. Most of these studies did not
focus on functional outcomes. Studies combining CGA
and intensive follow up after discharge are still scarce.
All patients that are included in the present study will
receive CGA during their hospital stay. The aim of the
present study is to investigate whether a transitional
care bridge program following discharge leads to a pre-
servation of physical functioning. The current paper
describes the methods that will be used in conducting
the study.
Methods
Design and setting
Three hospitals in the Netherlands will participate in
this multicentre, double-blind, randomised clinical trial
(RCT): the Academic Medical Center in Amsterdam
(AMC), a 1024-bed university teaching hospital, the
Onze Lieve Vrouwe Gasthuis in Amsterdam (OLVG), a
555-bed teaching hospital and the Flevo Hospital in
Almere, a 386-bed regional teaching hospital. The tran-
sition from hospital to home and home follow-up will
be provided by registered nurses affiliated with three
home care organisations connected to the hospitals;
Cordaan Home Care, Buurtzorg Nederland and Zorg-
groep Almere. The study is scheduled to start June 1,
2010 and will end after the last patient has been
followed up for six months. We expect the study to end
May 31, 2013.
Participants
All patients of 65 years and over acutely admitted to the
department of internal medicine of the three participat-
ing hospitals and hospitalised for at least 48 hours are
invited to participate. These patients are screened for
the risk for functional decline using the Identification of
Seniors at Risk-Hospitalized Patient (ISAR-HP, table 1,
in review). Patients with a score of two or more on this
screening instrument are at high risk for functional
decline and eligible for inclusion.
Patients are excluded if they are 1) terminally ill, 2) do
not give informed consent 3) transferred to Intensive
Care, Coronary Care Unit or to another ward within 48
hours after hospital admission, 4) came from another
department or another hospital 5) not fluent in the
Dutch languages or 5) came from a nursing home.
Patients presenting with cognitive impairment may par-
ticipate in the study.
Approvals
The study was approved by the AMC’s Medical Ethics
Committee which forms part of the University of
Amsterdam in the Netherlands (protocol ID MEC10/
082). Participants will provide written informed consent
prior to enrolment. In case of cognitive impairment
written informed consent will be obtained by the
patients’ primary care giver. Recruitment procedures will
be conducted in accordance with the Dutch Medical
Research Involving Human Subjects Act and the WMA
Declaration of Helsinki.
Randomisation and blinding
After obtaining informed consent and baseline assess-
ments, patients will be randomised into the intervention
or control group (figure 1). The randomisation proce-
dure will be website-based, using permuted blocks and
stratified by study centre and level of cognitive function-
ing (Mini-Mental State examination of ≥24 versus
MMSE scores of <24).
The study will be double-blinded as patients will be
blinded to the intervention by using a postponed
informed consent procedure described by Boter et al
[17]. This informed consent procedure is chosen
because we expect to introduce bias by informing all
patients about the intervention of study. Patients in the
control group could be unsatisfied with not being allo-
cated to the intervention group, whereas patients in the
intervention group could give better ratings to the inter-
vention. For example, patients might score higher out of
loyalty to the community care nurse that helped them.
Patients in the intervention group are further informed
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Page 2 of 9Table 1 Scorecard: Identification of Seniors At Risk - Hospitalized Patients (ISAR-HP)
ISAR-HP
YES NO
1. Before hospital admission, did you need assistance for IADL (e.g., assistance in housekeeping, preparing meals, shopping, etc.) on a
regular basis?
10
2. Do you use a walking device (e.g., a cane, walking frame, crutches, etc.)? 2 0
3. Do you need assistance for traveling? 10
4. Did you pursue education after age 14? 01
Total score (circled figures)
Total score 0 or 1 = not at risk.
Total score ≥2 = patient is at risk for functional decline.
Figure 1 Flow chart of patient selection and randomisation.
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about that this is the actual intervention to be studied.
The control group is not informed about the interven-
tion. After termination of the study, patients in both
study groups will receive written information concerning
the complete research question by means of a letter.
A research nurse blinded to the intervention will con-
duct all follow up assessments. The multidisciplinary
teams in the hospitals and the community care nurses
are not blinded to randomization.
Hospital care provided to all patients included in the
study
The geriatric consultation team in each of the hospitals
will consist of a geriatrician, Clinical Nurse Specialist
(CNS) in Geriatrics, Registered Nurse (RN), physiothera-
pist and a dietician. The RN will visit the participating
wards on a daily basis (except for the weekends) to
screen patients for eligibility. Patients at high risk for
functional decline, as determined by the ISAR-HP, will
receive a systematic comprehensive geriatric assessment
initially performed by the RN (table 2). The assessment
will start with screening on delirium, malnutrition, ADL
functions, mobility and fall risk. In cognitive impaired
patients, part of the CGA will be conducted by inter-
viewing the primary care giver. The primary care giver
will always be interviewed about burden of care givers
and the amount of time spent helping the patient at
home before admission.
Empowerment of patients and primary care givers is
an important topic in this study. After the CGA,
patients or their primary caregiver will be asked to indi-
cate which problems should be given highest priority for
treatment. Furthermore, attention will be given to
patients’ most important goals to be achieved during
and after hospital admission. This information will be
taken into account when discussing the outcome of the
CGA with the geriatrician and CNS.
A team meeting with the geriatric consultation team will
result in a tailor-made care- and treatment plan which will
be discussed with the patient and primary care giver. If
patients did not give priority to a certain problem and the
geriatric consultation team considers the problem relevant
to treat, the patient and primary care giver will be
informed about why the team advices to have a certain
condition treated and what are the treatment options.
Thus, the patient and primary care giver can make a well-
informed decision about the care and treatment plan.
The care and treatment plan will be carried out during
admission in accordance with the medical and nursing
care at the ward where the patient is admitted. If neces-
sary, other disciplines will be consulted, such as a phar-
macist or occupational therapist.
The intervention
The transitional care bridge program
The overall transitional care bridge program consists of
two steps; 1] the discharge procedure concerning the
transition of care and 2] the continuation of the inte-
grated care in the primary care by a community care
nurse.
Step 1: The experimental discharge procedure includ-
ing transition of care This step concerns the transfer of
care from hospital to primary care. The care during this
phase and the second phase will be provided by a com-
munity care nurse (CN). The CN is a bachelor level
educated nurse with a special focus on the elderly. The
CN can work in a general practice, within a home care
organisation or can be affiliated to a nursing home.
The transition from hospital to home consists of the
following sub-steps.
(a) A handover for the care and treatment plan is
made by the geriatric consultancy team and is coordi-
nated by the CNS as part of the integrated care plan at
least two days before discharge from hospital. This plan
includes the ongoing interventions and recommenda-
tions for care in the primary care setting.
(b) The transition of care-plan made by the CNS will
be offered to the primary care CN of the patient who is
visiting the patient in hospital before discharge.
(c) After visiting patient in the hospital, the CN will
discuss the care plan with the (substitute) General Prac-
titioner (GP) of the patient.
(e) Guided by the care and treatment plan handed
over from the hospital and depending on the needs of
the patients and caregiver, additional support will be
enabled by the CN (for example consisting of dietician,
occupational therapist, the elderly welfare consultant,
physiotherapist and/or pharmacist).
It is expected that approximately 6% of the patients
leaving hospital are not discharged home but will be
admitted in an intermediate care facility or rehabilitation
care in a nursing home. In this subgroup a CN from the
nursing home or rehabilitation centre will visit the
patient in the hospital.
Step 2: Experimental continuation of care in primary
care The intervention consists of the following steps
and will mainly be provided by the CN after discharge.
(a) The CN visits the patient within two days after
hospital discharge at home. In this first visit, special
attention is paid to medication and appropriateness of
care arranged during hospital admission.
(b) The second visit is two weeks after hospital dis-
charge where the CN (re)assesses the care- and treat-
ment plan and where needed the CN makes adaptations
to the plan and discusses clarity of the medication regi-
men from the hospital. In this visit, social functioning,
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Domain Question or instrument in CGA Condition/
Disease
SOMATIC
1. Mobility and stability Have you been fallen once or more in the past six months? Falls
Do you experience dizziness? Dizziness
Have you ever had a fracture? Osteoporosis risk
2. Medication Only if patients use medication
Do you experience difficulties or side effect with medication use?
Medication safety and side effects
Polypharmacy defined as the use or five or more different medications Polypharmacy
Medication adherence with the questionnaire of Aburuz [24] Medication adherence
3. Nutrition Short Nutritional Assessment Questionnaire (SNAQ) [25] Malnutrition
Was the patient dehydrated at admission? Dehydration
Difficulties with swallowing? Swallowing disturbance
Obesity or underweight
Body mass index Oral hygiene
Do you have pain in your mouth?
4. Urine and fecal problems Do you experience urine incontinence? Do you experience fecal incontinence Incontinence
Do you experience obstipation? Obstipation
Do you have an indwelling urinary catheter? Did you already have this at home? Indwelling urinary catheter use
5. Skin Do you have pressure ulcer(s)? Pressure ulcer
6. Pain Visual analogue scale for pain [26] Pain
7. Allergy Are you allergic? Allergy
PSYCHOLOGICAL
1. Delirium Have you ever experienced a delirium? Delirium
Confusement Assessment Method [27]
2. Depression Geriatric depression Scale [28,29] Depression
3. Cognition Mini-Mental State Examination [30] Cognitive impairement
4. Anxiety Do you feel anxious? Anxiety
5. Dependency Do you smoke? Alcohol, smoking and medication
use
Do you use alcohol
Do you use benzodiazepines?
FUNCTIONAL
1. ADL functioning Katz ADL index score [19] ADL dependency
2. IADL functioning IADL questions of Lawton and Brody [31] IADL dependency
3. mobility difficulty Are you using a walking aid? Mobility difficulty
4. Hearing Do you experience difficulties with hearing, despite the use of a hearing aid? Hearing impairment
5. Visual Do you experience difficulties with your vision, despite the use of glasses? Visual impairment
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Page 5 of 9participation and existing care needs will be discussed
with the patient.
(c) The CN will ensure continuation at home of the
interventions started in the hospital. When necessary, the
CN also coordinates indications for new interventions.
(d) The CN maintain contacts with other practitioners
(e.g. occupational therapy, dieticians, pharmacists, phy-
siotherapy, elderly welfare consultant etc.) in consulta-
tion with the general physician.
(e) The CN identifies new care/treatment needs (e.g.
imminent (re) admission to hospital) in consultation
with the GP
(f) The CN as transition coach also promotes the
empowerment of patients and carers by including the
provision of psycho-education on the identified geriatric
conditions and providing ancillary services such as lei-
sure, day treatment and care [18].
For patients discharged to a nursing home or rehabili-
tation centre, the same steps will be conducted but the
CN visit the patients in these settings and contacts the
Nursing Home Physician (NHP) for consultation
After 2, 6, 12 and 24 weeks, the CN visits the patients
and evaluates the care- and treatment plan, the impact
and the (intended) results. The results are discussed in
regular meetings of the primary care geriatric consultancy
team. This team consist of the GP (or NHP) and the CN,
and depending on patients care needs it is complemented
with a consultant pharmacist, a primary care physiothera-
pist, occupational therapist, elderly welfare consultant, die-
tician and/or a social worker. An in-hospital consultant
(geriatrician) is appointed at hospital discharge that can
also easily be consulted by the CN, GP or NHP.
The GP or the NHP remains the final responsible
director for the medical care of the patient.
Control group
Patients allocated to the control group will receive ‘care
as usual’ after discharge. This consists of a discharge
home after admission. The medical resident of the
hospital will send a discharge letter to the GP of the
patient that most often is received two weeks after dis-
charge. Additional care can be arranged with a home
care organisation and consists of help in conducting
ADL. Most patients are followed up six weeks after dis-
charge at the outpatient department. The consult mainly
consists of laboratory testing and focuses on the disease
(s) patients were discharged with.
Evidence based care and uniformity of care provided
The currently applied interventions in the integrated care
plan are all evidence based or based on current best prac-
tice in the hospital and in the community. For the pur-
pose of the present study an evidence based toolkit has
been constructed which describes the present state-of-
the-art in care and treatment of the geriatric conditions.
All geriatric conditions in this toolkit are worked out in
the same structure: goal to achieve with a certain condi-
tion, the theoretical background (prevalence, risk factors),
screening in the hospital and community care (which
question or validated instrument can be applied), action
plan, further diagnostics and how to apply these, evi-
dence based interventions (including when to consult
other disciplines) and financing care.
The toolkit will be used to create uniformity in
screening, diagnostics and interventions and is the basic
for the tailor-made care plan (available at http://www.
defencestudy.nl) [in Dutch].
Efforts to decrease the burden for very ill patients and
cognitive impaired patients
Attrition of frail older persons is a problem frequently
met in trials conducted in this patient population [7]. In
this randomised clinical trial, we have made efforts to
decrease all possible burden for these frail patients in
order to make it possible to include this group and to
minimize drop-outs.
At admission, the inclusion procedure for very ill
patients and cognitive impaired patients is limited. This
Table 2: Content of the Comprehensive Geriatric Assessment (CGA) performed at hospital admission (Continued)
6. Sleep Do you experience problems with sleeping? Sleeping disorder
Do you use sleeping medication? If yes, how often?
SOCIAL
1. Loneliness De Jong Gierveld-questionnaire [32] Loneliness
2. Burden of care giver Care giver extension of the Minimal Data set Burden of care giver
3. Health related quality of
life
EQ-6 D [22] Health related quality of life
The questions or instruments are a starting point for further diagnostics or treatment; if necessary a more intensive screening will be conducted by the
multidisciplinary team.
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conditions: delirium, malnutrition, activities of daily liv-
ing functioning, mobility and fall risk. This assessment
is chosen because these geriatric conditions contribute
most to adverse outcomes can be easily observed or
screened and are most prone to early intervention. If
patients are not able to answer question, the primary
care giver will be interviewed.
To build a strong and trusting relationship between
the CN and the patient and family, the starting point of
the intervention will be during hospital admission by
visiting patients during hospital admission. That way the
CN is a person more familiar to the patient and primary
care giver and they both know that the CN is informed
about the care provided in the hospital.
After discharge, all patients in the intervention group
will be visited in their own home to minimize the bur-
den of the visits.
Outcomes
Primary outcome
The primary outcome measure is the level of ADL func-
tioning six months after discharge from the hospital
compared to premorbid functioning two weeks prior to
hospital admission. The level of ADL functioning will be
measured with the Katz ADL index score [19]. The Katz
ADL index score consists of 6 items, with score range
from 0 to 6, with a higher score indicating more impair-
ment in ADL. At both time points, the questionnaire
will be filled in by the same person (patient or proxy,
depending on cognitive impairment)
Secondary outcomes
Secondary outcomes will be measured at baseline, three
months, six months and one year after discharge from
hospital by a research nurse who was blinded to the nat-
ure of the transitional care program. Secondary out-
comes include:
(1) Mortality
(2) ADL functioning, as measured with the ALDS, a
validated, Item Response Theory-based generic and vali-
dated continuous scale with a score range between 0
and 100, with a lower score expressing more impair-
ment in daily functioning [20]
(3) Cognitive functioning and health-related quality of
life (IQCODE-SF [21] and EQ-6 D [22])
(4) Experiences with providing care by primary care
givers and burden of primary care givers (with the pri-
mary care giver extension of the minimal dataset)
(5) Satisfaction of patients and primary care givers
with the care provided
(6) Health care utilization (economic extension of the
Minimal Dataset with care issues such as institutionali-
zation, rehospitalisation and/or visits to the emergency
department of the hospital, amount of care provided by
professional care and primary care giver).
Process evaluation
In addition to the primary and secondary outcomes
additional (semi-) qualitative data will be collected that
will give an insight in the feasibility of the transitional
care bridge intervention at the professional and AMC
geriatric network level. Qualitative data will be analyzed
in relation to primary care and hospital derived factors
that the future implementation of the care (might)
impede or promote.
Sample size calculation
In determining the appropriate group size in order to
demonstrate a significant intervention effect on the pri-
mary endpoint, we used Cohen’s effect size d to deter-
mine the difference between the patients’ KATZ ADL
index scores on the before and after measurement and
divided by the SD of the difference scores of the control
group as a benchmark for assessing the relative magni-
tude of ALDS score differences between both strategies.
Although an effect size of 0.25 can be defined as small,
such a difference in Katz ADL scores may be clinically
important.
We have demonstrated that with a total of 506
patients (253 patients per treatment arm) we are able to
statistically detect (power 80%, two-sided alpha of 5%) a
minimal effect size on the Katz ADL index score. To
allow for attrition due to mortality, which is expected to
be 25% six months after admission, a total of 674
patients will be included in the trial.
Data analysis
Statistical analyses will be based on an intention-to-treat
principle. Baseline assessments and outcome parameters
will be summarized using simple descriptive statistics.
The main analysis focuses on a comparison between the
trial intervention and control group of the primary out-
come, the Katz ADL index score. The same approach
will be used with regard to the secondary outcome para-
meters, including survival rates. Survival data will be
additionally analyzed using Kaplan-Meier survival curves
and the log-rank test.
We will perform a predefined subgroup analysis for
discharge destination (patients discharged to home ver-
sus nursing home). In all analyses statistical uncertain-
ties will be quantified via corresponding 95% confidence
intervals. Separate subgroup analysis will also be con-
ducted on patients at intermediate (ISAR-HP score of
two or three) and high risk for functional decline
(ISAR-HP score of four or five). Finally, process out-
come data will be analyzed qualitatively within the
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model [23].
Discussion
With an ageing population in many countries and
increasing life expectancy, there is an urgent need to
improve outcomes of hospital admission. Preservation of
decline in ADL functions and preventing institutionali-
zation have become a more important focus of care,
rather than only minimizing mortality rates. Several
approaches to improve hospital outcomes have been
studied focusing on comprehensive geriatric assessment
and intensive home follow up after discharge. The pre-
sent RCT combines these approaches to provide optimal
care during hospital admission and to improve ADL
functioning after discharge.
The study is conducted as part of the National Care
for the Elderly program in which special emphasis is
given to regional geriatric care networks. The current
study will provide information on the feasibility of the
intervention, collaboration between hospitals and pri-
mary care as well as on structural funding of care.
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